INS and Alzheimer disease: More than 30 years ago, William H. Frey II was the first to propose the use of intranasal administration of various biologically active substances, including polypeptide hormones and growth factors, for the treatment of Alzheimer’s disease and other diseases of the nervous system, and insulin was of the greatest interest among the studied hormones [131,132,133].